Key Takeaways
- Stable but challenged quarter: Revenue and profitability held steady despite a difficult chemical and agrochemical environment, with diversification into heavy engineering, mixing and systems offsetting glass lined weakness.
- Order intake turned a corner: A second consecutive quarter of strong order intake, led by heavy engineering, mixing and systems, supports confidence in hitting or slightly exceeding last year's revenue.
- Margins under pressure from low utilization: Lower backlog volume left factories under-absorbed, while competitive intensity squeezed pricing; cost control measures are underway but the payoff is a 9-12 month project.
- Diversification is the structural story: The company is deliberately reducing its 60-70% chemical/pharma exposure, targeting new industries with better growth and margin profiles, with a three-year strategic plan due in 3-6 months.
- What to watch next quarter: Whether the promised Q2 glass lined order intake materializes, the pace of heavy engineering's catch-up after a soft Q1, and any sign of agrochemical green shoots toward H2.
Demand Environment
- Chemical sector remains the drag: Agrochemicals face six to nine more months of slowdown driven by Chinese dumping at lower cost structures; specialty chemicals show some continuing investment with decisions now being taken.
- Pharma is the bright spot: Three or four very large projects are planned in Hyderabad pharma, mainly for glass lined business, expected to materialize in the coming weeks.
- International softness mirrors India: The chemical sector is soft globally, with overstocking and Chinese dumping affecting international markets as well.
- Diversification is the buffer: The slowdown in chemical and pharma, which still account for 60-70% of revenue, was mitigated by heavy engineering, mixing and systems businesses, which made up for the glass lined shortfall.
- Mixing benefits from segmentation: Mixing is more stable because its industries are much more segmented, giving more applications and markets to cater to compared to chemical and pharmaceuticals.
Thomas Kehl: "Mixing seems to be a little more stable because the entire mixing industries are much more segmented and gives us more applications and markets to cater to as compared to in chemical and pharmaceuticals."
Business Segment Performance
| Segment | Trend | Commentary |
|---|---|---|
| Glass Lined | ▼ Soft | Pricing under pressure from competitive intensity; India saw a significant reduction but heavy engineering and non-glass lined business in India made up the shortfall. |
| Heavy Engineering | ▬ Mixed | India HE had a soft Q1 but expected to make up the shortfall in Q2-Q4; internationally, services and systems gave good growth. |
| Mixing | ▲ Stable/Growing | Large order won with India, Canada and France collaborating; geographical expansion success in Australia with a large order and a follow-on from the same customer. |
| Systems | ▲ Strong orders | Multiple large orders won: ~$10 million US order in Q1, ~₹23 crores India order, additional $10-$15 million expected from Europe; inherently lumpy due to larger ticket sizes. |
| International | ▲ Strong execution | Services and systems are the big chunks internationally and delivered good growth; international execution remained strong. |
- Systems capability upgrade: The company invested in process experts and a test center in Karamsad, now fully operational, to move from equipment supplier to solution provider; in ~90% of systems orders, GMM designs the entire system including piping, instrumentation and automation.
- Glass lined margin squeeze: Margins have been relatively down for the past 2-3 quarters; as market leader the company gets a premium but tries to extract it only when possible given competitive intensity.
Tarak Patel: "Right now the market is still very highly competitive. Pricing is definitely under pressure. However, as a market leader, we do get premium, and we try to extract the premium as and when we can, but there is a lot of competitive intensity."
Margins & Cost
- The utilization problem: Margins are lower because volume in the backlog is not as high as in the past, leading to cost absorption issues across factories not being completely utilized.
- Competitive intensity adds pressure: Higher competitive intensity and pricing pressure from demand slowness compound the margin challenge.
- Cost control is a 9-12 month project: A project started a few weeks ago covering cost structure, procurement and value engineering at the manufacturing level; some benefits are already showing up, with many expected in ongoing quarters.
- Capacity utilization upside: Management expects a 2-3% addition to the bottom line from capacity utilization improvement alone.
- Employee cost managed down: Head count reduced across all functions in India and internationally; Q1 employee cost was lower than Q4 closing despite the increment cycle.
- No margin help from pricing: Margin improvement is expected from internal cost position improvements, not from pricing; market support in terms of volume is needed.
Strategic Direction
- Three-year plan incoming: The company plans to launch its three-year strategic plan in FY25, highlighting growth opportunities across platforms and regions; bottom-up numbers are being collected from every geography, business, platform and product line, with a public share targeted in the next 3-6 months.
- Deliberate diversification away from chemicals: The company expects to reduce its 60-70% chemical and pharma exposure over time, exploring new industries with strong double-digit growth and strong margin profiles where it can use its brand, capabilities and customer loyalty.
- New markets already in play: Mixing now caters to metals and minerals, rare earths, paints, dyes, food and beverage; systems does fermentation; heavy engineering covers oil and gas and petrochemicals.
- Mixing ambition: The mixing business is targeted to reach $100 million plus in three years, up from the current $45 million, implying a long-term growth aspiration of 25%.
- No expansion capex: No expansion capex is planned this year or most likely next financial year; maintenance capex will be much lower than the 2-2.5% run-rate.
- Acquisition appetite exists but nothing imminent: No current acquisitions in mind and nothing expected to close this financial year, but the company will look at acquisition opportunities for diversification into new industry segments.
Tarak Patel: "This year is basically a year for consolidation to look internally. ... We are not completely out of the woods, but definitely better off than what we were six to nine months ago."
Balance Sheet & Financing
- Debt refinanced and extended: The existing financing package, previously ending 2026, has been rolled over to 2028; an additional €40 million acquisition line was approved until August 2028.
- New banking relationships: New banking relationships have been initiated from India.
- Debt reduction path: No growth capex means no debt needed for capex; long-term debt is stable with approximately ₹100 crores reduction guided.
- Interest rate tailwind: International business debt is SOFR-linked, so interest rate reductions flow through as interest cost savings.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Revenue growth | Achieve or grow over last year's revenue; 5-10% growth expected | FY25 |
| EBITDA margin | Maintain ~13-13.5% consolidated; slight improvement if volumes pick up | FY25 |
| Glass lined order intake | Strong order intake expected | Q2 and Q3 FY25 |
| International order intake | Strong order intake expected | Next few quarters |
| Mixing business scale | Reach $100 million plus (from current $45 million) | Three years |
| Cost reduction project | Improve capacity, reduce cost, improve efficiency | 9-12 months |
| Debt reduction | ~₹100 crores reduction | FY25 |
| Three-year strategic plan | Public share of plan with growth opportunities across platforms and regions | Next 3-6 months |
| Capex | No expansion capex; maintenance capex below 2-2.5% | FY25 and likely FY26 |
Tarak Patel: "you won't see a lot of crazy numbers from us for the next few quarters, but then we do expect, in a year or two years from now you will see a company that is much more, I would..."
Key Metrics
| Metric | Q1 FY25 |
|---|---|
| Consolidated revenue | ₹785 cr, down ~13% YoY |
| Consolidated EBITDA | ₹89 cr |
| Consolidated EBITDA margin | 11.3%, vs ~13%-13.5% last year |
| Order intake | ₹882 cr, highest in eight quarters |
| Order backlog | ₹1,777 cr, up 5% |
| Revenue growth guidance FY25 | 5% to 10% growth expected |
| EBITDA margin guidance FY25 | ~13%-13.5%, maintaining last year's level; slight improvement possible if volumes pick up |
| Mixing business revenue share | 8% of consolidated revenue |
| Mixing business revenue target | $100 mn plus in three years, from $45 mn currently |
| Systems order intake | ~₹200 cr, vs ₹70 cr last year |
| Capacity utilization (India) | 55%-60%; Heavy Engineering at 90%-100% |
| Maintenance capex | ~2%-2.5% of revenue guided, but will be much lower this year |
| Growth capex | None anticipated this year or next financial year |
| Employee cost trend | Lower than Q4 closing numbers in India; international in line with Q4, slightly lower |
| Long-term debt reduction target | ~₹100 cr reduction guided for FY25 |